Stay updated with breaking news from Multiple Sclerosis Ms. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Certain risk factors can increase the odds of poor physical and mental quality of life decades after a patient receives a multiple sclerosis diagnosis, new research suggests.
Cognitive impairment may be a predictor of physical disability progression and future wheelchair dependence in patients with secondary-progressive multiple sclerosis, new research suggests.
The second-generation selective DHODH inhibitor vidofludimus calcium met a phase 2 trial primary endpoint of suppressing new active lesions on MRI and was well tolerated.
COVID rates after vaccination are relatively low and cases mild in patients with multiple sclerosis treated with disease-modifying therapies – but vaccine antibody response is lower with anti-CD20 therapies.
The first randomized trial to examine if older adults with multiple sclerosis can discontinue disease-modifying therapy after years of being relapse-free failed to deliver a definitive conclusion.